Phase
Condition
Myocardial Ischemia
Vascular Diseases
Thrombosis
Treatment
Ultra-low strut thickness everolimus-eluting biodegradable polymer Evermine50 stent(s)
PCI with Everolimus-eluting stents (durable polymer everolimus-eluting Xience or Promus stent(s))
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- All patients aged ≥18 years who are eligible for treatment with one or severaldrug-eluting coronary stents
Exclusion
Exclusion Criteria:
Age < 18 years
Not able to consent to study participating (eg. intubated patients)
Unstable circuit or in cardiogenic shock and therefore not able to understand theinformation and purpose of the study
Do not speak Danish
Already included in the SORT OUT XII study
Life expectancy <1 year
Allergic to study related treatment
Study Design
Connect with a study center
Aalborg University Hospital
Aalborg, 9000
DenmarkActive - Recruiting
Aarhus University Hospital
Aarhus, 8200
DenmarkActive - Recruiting
Odense University Hospital
Odense, 5000
DenmarkActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.